Syncona Partners
Investor profile
Venture capital
Also recorded as: Syncona Investment Management · Syncona Limited · Syncona Partners LLP · Syncona Partners LLP.
Deals
12
distinct rounds
Companies
10
backed
Active span
2014–2024
11 yrs
Total round €
€770M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Jeito Capital2
- New Science Ventures2
- Wellington Partners2
- 3B Future Health Fund1
- British Patient Capital1
- Cambridge Enterprise1
- Cambridge Innovation Capital1
- Cowen Healthcare Investments1
- EcoR1 Capital1
- EIC Fund1
- Eventide Asset Management1
- Fidelity Management & Research Company LLC1
- Forbion1
- GV1
- GV (Google Ventures)1
- INKEF Capital1
- Janus Henderson Investors1
- M Ventures1
- Monashee Investment Management LLC1
- New Enterprise Associates1
- Northpond Ventures1
- Novartis Venture Fund1
- Novo Holdings1
- Oxford Science Enterprises1
- Oxford University Innovation Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Anaveon | Switzerland | 2 | €136M |
| Freeline Therapeutics | UK | 1 | €107M |
| Neogene Therapeutics | Netherlands | 1 | €93M |
| OMass Therapeutics | UK | 1 | €90M |
| iOnctura | Switzerland | 1 | €80M |
| Nightstar | UK | 1 | €41M |
| Azeria Therapeutics | UK | 1 | €36M |
| Mosaic Therapeutics | UK | 1 | €25M |
| Cambridge Epigenetix | UK | 2 | €24M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Anaveon | Series B | €106M | 2021-12 |
| Neogene Therapeutics | Other | €93M | 2020-09 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| iOnctura | Series B | €80M | 2024-06 |
| Nightstar | Series C | €41M | 2017-07 |
| Azeria Therapeutics | Series B | €36M | 2019-09 |
| Anaveon | Series A | €30M | 2018-12 |
| Mosaic Therapeutics | Series A | €25M | 2023-04 |